Pluristem Therapeutics Inc. Logo
Pluristem Therapeutics Announces Interim Top-Line Results From PLX-PAD Clinical Trials
April 27, 2010 07:10 ET | Pluristem Therapeutics, Inc.
HAIFA, Israel, April 27, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced interim top-line results from its Phase I clinical trials utilizing its...
Pluristem Therapeutics Inc. Logo
Pluristem Therapeutics Raises $2.7 Million in Private Placement of Restricted Common Stock
April 27, 2010 07:00 ET | Pluristem Therapeutics, Inc.
HAIFA, Israel, April 27, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced that it has entered into definitive agreements with selected investors to sell...
Pluristem Therapeutics Inc. Logo
Pluristem Therapeutics Granted European Union Patent for PluriX(TM) Three-Dimensional (3D) Bioreactor System
March 23, 2010 08:32 ET | Pluristem Therapeutics, Inc.
HAIFA, Israel, March 23, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced that it has been granted a European Patent on its core 3D cell expansion...
Pluristem Therapeutics Inc. Logo
Pluristem to Present at the ROTH 22nd Annual OC Growth Conference
March 09, 2010 08:00 ET | Pluristem Therapeutics, Inc.
HAIFA, Israel, March 9, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced its participation in the Roth 22nd Annual OC Growth Conference to be held at The...
Pluristem Therapeutics Inc. Logo
Pluristem Therapeutics Receives DSMB Approval to Advance to Final Dose Level With PLX-PAD
March 02, 2010 08:00 ET | Pluristem Therapeutics, Inc.
HAIFA, Israel, March 2, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced that it has received approval from an independent Data Safety Monitoring Board...
Pluristem Therapeutics Inc. Logo
Pluristem Therapeutics Completes Dosing of First Group of Patients in Europe With Placenta-Derived Cell Therapy Product PLX-PAD in Phase I Clinical Trial for Treatment of Critical Limb Ischemia (CLI)
December 01, 2009 08:00 ET | Pluristem Therapeutics, Inc.
HAIFA, Israel, Dec. 1, 2009 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced that it has completed dosing of the first of three dosage groups of patients in...
Pluristem Therapeutics Inc. Logo
Pluristem Provides Disclosure Pursuant to NASDAQ Marketplace Rule 5250(b)(2)
October 01, 2009 18:45 ET | Pluristem Therapeutics, Inc.
HAIFA, Israel, Oct. 1, 2009 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced, that on September 23, 2009, it filed its Annual Report on Form 10-K with the SEC,...